Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Capital Group Growth ETF
CGGR
$25.3B
| $22.7M | ﹤0.01% |
709,003
+611,173
| +625% | +$18.4M |
|
2552
VanEck Short High Yield Muni ETF
SHYD
$452M
| $22.6M | ﹤0.01% |
1,010,112
-944,018
| -48% | -$21M |
|
2553
Nuveen Real Asset Income & Growth Fund
JRI
$347M
| $22.6M | ﹤0.01% |
1,908,248
-2,054,306
| -52% | -$23.9M |
|
2554
nCino
NCNO
$2.11B
| $22.6M | ﹤0.01% |
604,181
+243,345
| +67% | +$7.66M |
|
2555
Trinity Industries
TRN
$2.56B
| $22.6M | ﹤0.01% |
810,919
-1,074,405
| -57% | -$27.7M |
|
2556
Maravai LifeSciences
MRVI
$953M
| $22.6M | ﹤0.01% |
2,604,766
-3,133,530
| -55% | -$21.2M |
|
2557
Liberty All-Star Equity Fund
USA
$1.84B
| $22.5M | ﹤0.01% |
3,151,614
-3,993,562
| -56% | -$26.7M |
|
2558
Altimmune
ALT
$587M
| $22.5M | ﹤0.01% |
2,211,948
+130,146
| +6% | +$1.32M |
|
2559
Fate Therapeutics
FATE
$310M
| $22.5M | ﹤0.01% |
3,065,789
+423,077
| +16% | +$2.62M |
|
|
IBTX
2560
DELISTED
Independent Bank Group, Inc.
IBTX
| $22.5M | ﹤0.01% |
492,895
-765,811
| -61% | -$35.7M |
|
2561
WisdomTree International High Dividend Fund
DTH
$656M
| $22.5M | ﹤0.01% |
567,751
-446,537
| -44% | -$17.2M |
|
2562
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$927M
| $22.5M | ﹤0.01% |
518,305
-323,839
| -38% | -$14.1M |
|
2563
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
| $22.5M | ﹤0.01% |
2,130,115
-1,738,123
| -45% | -$17.7M |
|
2564
Central Garden & Pet Co Class A
CENTA
$2.42B
| $22.5M | ﹤0.01% |
608,767
-604,298
| -50% | -$21.4M |
|
2565
WisdomTree US High Dividend Fund
DHS
$1.57B
| $22.5M | ﹤0.01% |
259,232
-325,452
| -56% | -$26.8M |
|
|
STR
2566
DELISTED
Sitio Royalties
STR
| $22.4M | ﹤0.01% |
906,973
-704,609
| -44% | -$15.9M |
|
2567
Liberty Global Class C
LBTYK
$3.52B
| $22.4M | ﹤0.01% |
1,269,718
-1,357,474
| -52% | -$26.1M |
|
2568
DNOW Inc
DNOW
$2.6B
| $22.4M | ﹤0.01% |
1,473,119
-1,388,803
| -49% | -$16.8M |
|
2569
Brady Corp
BRC
$4.6B
| $22.4M | ﹤0.01% |
377,400
-1,825,898
| -83% | -$109M |
|
2570
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.03B
| $22.3M | ﹤0.01% |
408,310
-366,108
| -47% | -$19.9M |
|
|
ECHO
2571
EchoStar
ECHO
$25.8B
| $22.3M | ﹤0.01% |
1,567,623
+150,105
| +11% | +$2.09M |
|
2572
VanEck Agribusiness ETF
MOO
$973M
| $22.3M | ﹤0.01% |
297,179
-332,343
| -53% | -$24.2M |
|
2573
Eagle Bancorp
EGBN
$858M
| $22.3M | ﹤0.01% |
948,053
-337,415
| -26% | -$8.36M |
|
|
ITOS
2574
DELISTED
iTeos Therapeutics
ITOS
| $22.3M | ﹤0.01% |
1,632,356
-630,630
| -28% | -$6.87M |
|
2575
State Street SPDR S&P Health Care Equipment ETF
XHE
$160M
| $22.3M | ﹤0.01% |
253,027
-503,355
| -67% | -$42.7M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.